Oriola Oyj (LON:0NES)

Market Cap	153.52M -13.6%
Revenue (ttm)	1.66B +13.4%
Net Income	-23.73M
EPS	-0.13
Shares Out	n/a
PE Ratio	n/a
Forward PE	8.01
Dividend	0.03 (2.68%)
Ex-Dividend Date	Mar 26, 2026

Volume	14,682
Average Volume	16,391
Open	0.9640
Previous Close	0.9675
Day's Range	0.9540 - 0.9640
52-Week Range	0.9540 - 1.2500
Beta	0.43
RSI	27.96
Earnings Date	Apr 29, 2026

About Oriola Oyj

Oriola Oyj engages in the wholesale of pharmaceuticals and health products in Sweden, Finland, and internationally. The company distributes vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products; vaccines; and over-the-counter products. In addition, it provides pharmaceutical logistics; special licensed medicine importing, dose dispensing, and research pharmacy services; and commercial data, clinical trial, regulatory affairs and quality, medical and scientific affairs, market access and tenders, ...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1907
• Employees: 904
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0NES

Financial Performance

In 2025, Oriola Oyj's revenue was 1.91 billion, an increase of 13.40% compared to the previous year's 1.68 billion. Losses were -27.20 million, 35.3% more than in 2024.

Financial numbers in EUR